Outcomes of 6-9-12 months’ bedaquiline-containing regimens in MDR/XDR TB after 24 months follow up

S. Borisov (Moscow, Russian Federation), A. Filippov (Moscow, Russian Federation), T. Ivanushkina (Moscow, Russian Federation), D. Ivanova (Moscow, Russian Federation), Y. Garmash (Moscow, Russian Federation)

Source: International Congress 2018 – Drug-resistant tuberculosis
Session: Drug-resistant tuberculosis
Session type: Poster Discussion
Number: 3671
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Borisov (Moscow, Russian Federation), A. Filippov (Moscow, Russian Federation), T. Ivanushkina (Moscow, Russian Federation), D. Ivanova (Moscow, Russian Federation), Y. Garmash (Moscow, Russian Federation). Outcomes of 6-9-12 months’ bedaquiline-containing regimens in MDR/XDR TB after 24 months follow up. 3671

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: